Finalmente, los beneficios renales de los arGLP-1 parecen aditivos a los de los iSGLT2, lo que es especialmente interesante en pacientes con ERD85,86,103
Posttranslational regulation of Akt in human cancer
Exclusive: UK probes Novos Ozempic, weight-loss drug Saxenda over suicidal, self-harming thoughts
Evaluation of the effects of sodium-glucose co-transporter 2 inhibition with empagliflozin on morbidity and mortality in patients with chronic heart failure and a preserved ejection fraction: rationale for and design of the EMPEROR-Preserved trial
Using FDA-approved therapies like tirzepatide and semaglutide with close medical supervision, patients achieve meaningful, sustained weight loss and improved metabolic health
Jalleh RJ, Plummer MP, Marathe CS, et al